bollyky: none. kristen: how would you say the efficacy -- in recent days we have been hearing the pfizer vaccine after 120 days becomes 77%, as opposed to 95% initially. do you have data on that? dr. bollyky: i do not. this is a placebo-controlled study. for every two people getting the medication, one is not. i do not know who is getting it and who is not. we have not had significant number of cases in our population, but i can't tell you who is getting the medicine and who is not. kristen: we talked about more steps. full data, peer review, cdc, when do you expect the shop will actually go into young arms? dr. bollyky: based on what we have seen, it is usually a month for the fda to review, i am hopeful this will start to see rollout for this age group next month before halloween. kristen: what about. there is nothing magic about five. what about preschool? younger than five? dr. bollyky: we participated in a dose finding part of the study , the phase one study. the age groups are broken down from